Two Sigma Advisers’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-765,550
| Closed | -$15.4M | – | 2867 |
|
|
2021
Q3 | $15.4M | Buy |
765,550
+421,200
| +122% | +$8.49M | 0.04% | 374 |
|
|
2021
Q2 | $12.9M | Sell |
344,350
-6,800
| -2% | -$254K | 0.03% | 475 |
|
|
2021
Q1 | $8.98M | Sell |
351,150
-180,900
| -34% | -$4.63M | 0.02% | 623 |
|
|
2020
Q4 | $11.7M | Sell |
532,050
-123,300
| -19% | -$2.72M | 0.03% | 516 |
|
|
2020
Q3 | $11.8M | Buy |
655,350
+32,800
| +5% | +$590K | 0.03% | 491 |
|
|
2020
Q2 | $15.8M | Buy |
622,550
+4,300
| +0.7% | +$109K | 0.05% | 391 |
|
|
2020
Q1 | $11.4M | Buy |
618,250
+177,700
| +40% | +$3.26M | 0.04% | 438 |
|
|
2019
Q4 | $9.71M | Buy |
440,550
+348,600
| +379% | +$7.68M | 0.02% | 607 |
|
|
2019
Q3 | $1.32M | Sell |
91,950
-27,600
| -23% | -$396K | ﹤0.01% | 1314 |
|
|
2019
Q2 | $1.88M | Sell |
119,550
-14,700
| -11% | -$232K | ﹤0.01% | 1238 |
|
|
2019
Q1 | $1.97M | Sell |
134,250
-31,300
| -19% | -$459K | 0.01% | 1236 |
|
|
2018
Q4 | $1.77M | Sell |
165,550
-21,400
| -11% | -$229K | ﹤0.01% | 1225 |
|
|
2018
Q3 | $2.85M | Buy |
186,950
+28,100
| +18% | +$429K | 0.01% | 1056 |
|
|
2018
Q2 | $1.95M | Buy |
158,850
+148,750
| +1,473% | +$1.82M | 0.01% | 1309 |
|
|
2018
Q1 | $97K | Buy |
+10,100
| New | +$97K | ﹤0.01% | 2229 |
|